Squarepoint’s Mural Oncology MURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-175,502
Closed -$565K 5128
2024
Q4
$565K Buy
175,502
+2,470
+1% +$8.71K ﹤0.01% 3624
2024
Q3
$542K Buy
173,032
+5,388
+3% +$17.5K ﹤0.01% 3033
2024
Q2
$526K Buy
167,644
+29,683
+22% +$109K ﹤0.01% 3035
2024
Q1
$675K Sell
137,961
-98,024
-42% -$476K ﹤0.01% 2855
2023
Q4
$1.4M Buy
+235,985
New +$949K ﹤0.01% 2274

Other funds holding MURA

Squarepoint's MURA Position: Q1 2025 in Review

Squarepoint sold out of Mural Oncology (MURA) in Q1 2025, closing a stake of 175,502 shares — an estimated $565K sold.

Squarepoint first reported a position in MURA in Q4 2023 and held it in 5 quarters. The position peaked at $1.4M in Q4 2023. 68 funds tracked by Wall St. Rank hold MURA as of Q1 2025.

  • Squarepoint reported no remaining Mural Oncology position as of Q1 2025 after selling out during the quarter.
  • Squarepoint sold 175,502 Mural Oncology shares in Q1 2025, an estimated $565K.
  • Squarepoint first reported a position in Mural Oncology in Q4 2023 and held it in 5 quarters.
  • Squarepoint's Mural Oncology position peaked at $1.4M in Q4 2023.
  • 68 funds tracked by Wall St. Rank held Mural Oncology as of Q1 2025.

Based on Squarepoint's 13F filing for Q1 2025, filed 15 May 2025.